178 related articles for article (PubMed ID: 33685075)
1. [From treatable to curable to eliminated ---- a decade of research progress in the diagnosis and treatment of hepatitis C].
Rao HY; Wei L
Zhonghua Gan Zang Bing Za Zhi; 2021 Feb; 29(2):102-107. PubMed ID: 33685075
[TBL] [Abstract][Full Text] [Related]
2. [In-hospital process for viral hepatitis C screening and management in China (Draft)].
; ; ;
Zhonghua Gan Zang Bing Za Zhi; 2021 Apr; 29(4):319-325. PubMed ID: 33979957
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapy.
Lazarus JV; Picchio CA; Guy D; Aleman S; James C; Nava FA; Øvrehus A; Turnes J; Ward JW; Ustianowski A
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101564. PubMed ID: 33740477
[TBL] [Abstract][Full Text] [Related]
4. The Road to Hepatitis C Virus Cure: Practical Considerations from a Health System's Perspective.
Jonas MC; Loftus B; Horberg MA
Infect Dis Clin North Am; 2018 Jun; 32(2):481-493. PubMed ID: 29778267
[TBL] [Abstract][Full Text] [Related]
5. [Chronic hepatitis C: achievement, challenge and strategy to eliminate as a public health threat].
Wei L
Zhonghua Gan Zang Bing Za Zhi; 2018 Mar; 26(3):161-168. PubMed ID: 29804387
[TBL] [Abstract][Full Text] [Related]
6. Simplification of Care for Chronic Hepatitis C Virus Infection.
Pawlotsky JM; Ramers CB; Dillon JF; Feld JJ; Lazarus JV
Semin Liver Dis; 2020 Nov; 40(4):392-402. PubMed ID: 32725611
[TBL] [Abstract][Full Text] [Related]
7. Simplified treatment of hepatitis C: another strategy to overcome the barriers to its elimination.
Ridruejo E; Mendizabal M; Silva MO
Medicina (B Aires); 2021; 81(2):252-256. PubMed ID: 33906144
[TBL] [Abstract][Full Text] [Related]
8. A platform in the use of medicines to treat chronic hepatitis C (PLATINUM C): protocol for a prospective treatment registry of real-world outcomes for hepatitis C.
Ramsay J; Marsh J; Pedrana A; Andric N; Norman R; Cheng W; Webb S; Zeps N; Bellgard M; Graves T; Hellard M; Snelling T
BMC Infect Dis; 2020 Oct; 20(1):802. PubMed ID: 33121439
[TBL] [Abstract][Full Text] [Related]
9. Optimism and eternal vigilance: Gathering disease, responsible subjects and the hope of elimination in the new hepatitis C treatment era.
Nourse G; Farrugia A; Fraser S; Moore D; Treloar C
Int J Drug Policy; 2023 Sep; 119():104142. PubMed ID: 37591009
[TBL] [Abstract][Full Text] [Related]
10. Changing Urban-Rural Disparities in the Utilization of Direct-Acting Antiviral Agents for Hepatitis C in U.S. Medicare Patients, 2014-2017.
Du P; Wang X; Kong L; Riley T; Jung J
Am J Prev Med; 2021 Feb; 60(2):285-293. PubMed ID: 33221144
[TBL] [Abstract][Full Text] [Related]
11. [Antiviral therapy of chronic hepatitis C: 30 years success story].
Abdurakhmanov DT; Rozina TP; Nikulkina EN; Burnevich EZ; Tanashuk EL; Severov MV; Filatova AL; Milovanova SY; Karpov VV; Moiseev SV
Ter Arkh; 2019 Nov; 91(11):110-115. PubMed ID: 32598621
[TBL] [Abstract][Full Text] [Related]
12. [Price analyses on direct-acting antiviral drugs of hepatitis C].
Duan CAX; Sui BY; Chen ZD; Zhao K
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Oct; 54(10):1161-1164. PubMed ID: 33115205
[TBL] [Abstract][Full Text] [Related]
13. Management of in- and out-of-hospital screening for hepatitis C.
Zhou J; Wang FD; Li LQ; Chen EQ
Front Public Health; 2022; 10():984810. PubMed ID: 36761331
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Hepatitis C Patients in the Direct-Acting Antiviral Era.
Teriaky A; Reau N
Clin Liver Dis; 2015 Nov; 19(4):591-604, v. PubMed ID: 26466649
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness and safety of direct-acting antiviral agents for treatment of patients with chronic hepatitis C virus infection].
Yang J; Rao HY
Zhonghua Gan Zang Bing Za Zhi; 2018 Mar; 26(3):175-178. PubMed ID: 29804389
[TBL] [Abstract][Full Text] [Related]
16. Chronic Hepatitis C Infection in Children.
Pham YH; Rosenthal P
Adv Pediatr; 2016 Aug; 63(1):173-94. PubMed ID: 27426900
[No Abstract] [Full Text] [Related]
17. Is resistance to direct-acting antivirals in sub-Saharan Africa a threat to HCV elimination? Recommendations for action.
Gupta N; Kateera F; Desalegn H; Ocama P; Njouom R; Lacombe K
J Hepatol; 2020 Mar; 72(3):583-584. PubMed ID: 31836263
[No Abstract] [Full Text] [Related]
18. Towards curative therapy of chronic viral hepatitis.
Bartenschlager R; Urban S; Protzer U
Z Gastroenterol; 2019 Jan; 57(1):61-73. PubMed ID: 30641605
[TBL] [Abstract][Full Text] [Related]
19. Management of Hepatitis C Infection in children in the era of Direct-acting Antiviral Agents.
Karnsakul W; Schwarz KB
J Viral Hepat; 2019 Sep; 26(9):1034-1039. PubMed ID: 30980688
[TBL] [Abstract][Full Text] [Related]
20. [Guidelines for the prevention and treatment of hepatitis C (2019 version)].
;
Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):962-979. PubMed ID: 31941258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
